Oruka Therapeutics ORKA
NASDAQ ORKA
$84.52 +1.10 (+1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Sales of Property, Plant and Equipment (2011)

Updated

Oruka Therapeutics' Sales of Property, Plant and Equipment came in at $23,000 for Q4 2011.

Analysis

Oruka Therapeutics (ORKA) Sales of Property, Plant and Equipment (2011) Analysis & Trends

For FY2011, Oruka Therapeutics' Sales of Property, Plant and Equipment was $25,000, up 316.7% from FY2010.

  • Going back by year, Sales of Property, Plant and Equipment was $6,000 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Oruka Therapeutics 5.31 Bn 3.37 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 23,000.00
Sep 30, 2011 1,000.00
Mar 31, 2011 1,000.00
API Access

Oruka Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=ORKA&period=max&api_key=YOUR_API_KEY